Institut CurieParis, Ile-de-France, France
Disclosure information not submitted.
Paper 17 - INTEREST OF A SEQUENTIAL MULTIMODAL APPROACH FOR THE TREATMENT OF NEWLY DIAGNOSED PATIENTS WITH MULTIMETASTATIC EWING SARCOMA: RESULTS OF THE FRENCH PROSPECTIVE COMBINAIR3 PHASE II TRIAL
Thursday, November 14, 20241:45 PM – 3:15 PM PST
Paper 47 - TARGETING DEDIFFERENTIATED LIPOSARCOMA CELL OF ORIGIN WITH TGF-BETA INHIBITION
Friday, November 15, 20249:00 AM – 10:00 AM PST